Selective androgen receptor modulators and methods for their identification, design and use

Details for Australian Patent Application No. 2001288213 (hide)

Owner Bristol-Myers Squibb Company

Inventors Krystek Jr., Stanley R.; Gottardis, Marco M.; Salvati, Mark E.; Sack, John S.; Attar, Ricardo M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001288213

PCT Pub. Number WO02/00617

Priority 60284730 18.04.01 US; 60284438 18.04.01 US; 60233519 19.09.00 US; 60284617 18.04.01 US; 60214392 28.06.00 US

Filing date 20 June 2001

Wipo publication date 8 January 2002

Acceptance publication date 14 April 2005

International Classifications

A61K 038/00 Medicinal preparations containing peptides

Event Publications

14 April 2005 Application Accepted

  Published as AU-B-2001288213

11 August 2005 Standard Patent Sealed

8 February 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001288214-Transgenic mice containing targeted gene disruptions

2001288212